RareCan Newsletter Firstly, thank you to everyone who has signed up to RareCan to become a member, we would not be anywhere without your support
Cancer Survival Rates At RareCan, we find it really frustrating that research into rare cancer is limited and that the survival rate for people with
Jo’s Malignant Melanoma Story ‘Being diagnosed with a Malignant Melanoma in my early 40’s was not part of my life plan.’ A difficult experience with
Celebrating 100 Members! 100 members is a significant milestone in the development of RareCan. It is 100 people with cancer, predominantly GIST or PAWS GIST
Mandashi Invests in RareCan We urgently need to increase treatment options and improve outcomes for people with rare cancer. At RareCan, we are working with
NovoPath & RareCan Partnership Analysing samples from tumours lies at the heart of the discovery of new forms of treatment for cancer. Rare Cancers are
Research is Key to Beating Cancer Steve joined RareCan last year to make himself available to researchers and help improve treatment for rare cancers. My
Lessons from the Coronavirus Vaccine Why can’t medical advances always be this quick? The Chinese released the genetic sequence of the coronavirus on January 12th.
RareCan Live Discussion We’re really proud to present the first in a series of RareCan discussions. The topic of today’s conversation is rare cancer. Debbie
The Importance of Collaborating with Patients My first day’s paid employment after leaving school was through a nursing agency; a naïve 18 year old, thrust
RareCan Limited is a company registered in England, number 12844377. Registered office address: 8 Park Avenue, Hexham, England, NE46 3EN. 0191 249 8555
